A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
Settled end to Saturday and start to Sunday. Showers to begin, rain to end. Here's the latest forecast for the weekend ahead
Manager Mark Hughes is confident Stoke will offer Jese Rodriguez the perfect platform to show why he is one of Europe's elite players.
Police in Merseyside have asked for members of the public to come forward with information relating to cannabis farms in their communities.